AI+VR BASED digital

therapeutics for
neuro-muscular conditions



JOGO uses wearables and an App that leverages AI and VR to treat neuromuscular conditions and chronic pain by providing treatment protocols and games that can be adapted for muscle relaxation, movement coordination, and neuro-muscular re-education all leveraging the clinically proven science of neuroplasticity.


JOGO therapy is provided as JaaS (JOGO as a Service) at a doctor's office, patient's home or via Telemedicine. JOGO-Gx (Non VR) received FDA 510k exemption in March 2020 during COVID-19 and is reimbursed by Medicare and commercial payers.

Pathways between two neurons get damaged for patients with neuro-muscular conditions

Exercising with JOGO triggers neural plasticity – development of new pathways between neurons

Brain creates new pathways to work with inactive muscles or addressing pain

Our Story

​Someone in the United States has a stroke every 40 seconds. Every year, worldwide, more than 15 million people have a stroke, 795,000 people in the United States alone. 3 in 1000 children are born with cerebral-palsy.  35% of adult women and 75% of Multiple Sclerosis patients have stress urinary incontinence(SUI).  With nine years of tireless research and testing, we have created JOGO as a potential prescription digital therapy to treat more than ten neuromuscular conditions. In 2019, JOGO received the patent for the innovation from United States Patent and Trademark Office (USPTO).

The word "jogo" means “game” in Portuguese and is also our tribute to the pioneering work of Dr. Joe Brudny and Dr. Gordon Silverman which paved the foundation for our product. JOGO is the creation of entrepreneurs, product design specialists, technology enthusiasts, physical therapy professionals, physiatrists, data scientists, and game designers.

  • Twitter
  • YouTube
  • Facebook


JOGO-Gx is FDA 510 (K) Exempt. FDA registration number.: 3016735640.

FDA Owner Operator Number: 10069814

US Group National Provider Number (NPI) 1013537349